The funds will be raised by way of issue of GDRs/ADRs /FCCBs/QIP or such other equity linked instruments Strides Arcolab plans to raise Rs 1500 crore through various market instruments “The Board of ...

Strides Arcolab Ltd, a Bangalore-based pharmaceutical company, has received its board’s approval to raise up to Rs 1,500 crore ($226.8 million) including a green-shoe option, according to a stock ...

New Delhi: Drug firm Strides Arcolab will acquire a majority stake in the India-branded generics business of Bafna Pharmaceuticals for a cash consideration of Rs 48.1 crore. The two companies have ...

Bangalore-based pharmaceutical company Strides Arcolab Ltd has struck a deal to acquire a bunch of brands from Johnson & Johnson (J&J) besides inking a separate agreement to buy a majority stake in ...

National Building Construction Corporation (NBCC) shares gained as much as 2.5 per cent on Friday after the company informed bourses that it has secured orders of Rs 17,516.53 crore in 2015-16. Shares ...

New Delhi: Drug firm Strides Arcolab has made a series of investments in bio-pharmaceutical firm Oncobiologics Inc, acquiring a stake in the US based company. Strides Arcolab and Oncobiologics Inc ...

Strides Arcolab, listed on the Bombay Stock Exchange Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical Company headquartered in Bangalore, India that ...

NEW DELHI: Drug firm Strides Arcolab has received approval from the US health regulator for its Benzonatate softgel capsules used for treating cough caused by cold, and other breathing problems such ...

Seamless reading experience. Save your favourite. It added: "The fund raising is subject to shareholders' approval and such other statutory approvals as may be required including that of Foreign ...

"We’ve been able to squeeze the rupee and create a lot of value. You must assume that we’ll do it again," says Arun Kumar, without any hint of hubris. The founder and group chief executive of Strides ...

Bangalore-based Strides Arcolab Ltd has sold its entire 94 per cent holding in Ascent Pharma Health Ltd, its subsidiary operating in Australia and South-east Asia, to NYSE-listed Watson ...

Drug firm Strides Arcolab today said it has received approvals from the US health regulator for generic Fluorouracil Injection used for treating several types of cancer. The company's wholly-owned ...